Research Library

A curated index of peer-reviewed publications and clinical trial data relevant to the compounds available at Synthetix Labs. All references are publicly available via PubMed or official trial registries. This library is provided for educational and research reference purposes only.

Recovery & Tissue Repair

BPC-157

  • Sikiric P, et al. (2018). Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. PubMed
  • Chang CH, et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology.
  • Gwyer D, et al. (2019). Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research.

TB-500 (Thymosin Beta-4)

  • Goldstein AL, et al. (2012). Thymosin β4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy.
  • Philp D, et al. (2004). Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mechanisms of Ageing and Development.

Growth & GH Axis

Ipamorelin

  • Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.

CJC-1295

  • Teichman SL, et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism.

Tesamorelin

  • Falutz J, et al. (2010). Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation. AIDS.

Sermorelin

  • Walker RF. (2006). Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging.

Metabolic

Semaglutide

  • Wilding JPH, et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine.
  • Marso SP, et al. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6). New England Journal of Medicine.

Tirzepatide

  • Jastreboff AM, et al. (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine.
  • Frias JP, et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). New England Journal of Medicine.

Retatrutide

  • Jastreboff AM, et al. (2023). Triple-hormone-receptor agonist retatrutide for obesity (SURMOUNT-4 phase 2). New England Journal of Medicine.

AOD-9604

  • Heffernan M, et al. (2001). The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice. Endocrinology.

Nootropic

Selank

  • Semenova TP, et al. (2010). Selank and semax affect the expression of genes related to the immune and opioid systems. Doklady Biological Sciences.

Semax

  • Dolotov OV, et al. (2006). Semax, an analogue of ACTH(4-7), regulates BDNF and trkB expression in the rat hippocampus. Journal of Neurochemistry.

Longevity

Epitalon

  • Khavinson VK, et al. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine.

NAD+

  • Yoshino J, et al. (2018). NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism.
  • Verdin E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science.

MOTS-c

  • Lee C, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism.

Cosmetic

GHK-Cu

  • Pickart L, et al. (2015). GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes. Cosmetics.

Melanotan II

  • Dorr RT, et al. (1996). Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences.

All references are provided for informational and research purposes only. Synthetix Labs does not make any therapeutic claims. Products are for research use only and not intended for human consumption.